States had restricted Medicaid recipients’ access to drugs, but new court rulings are changing that practice.
Researchers find that direct-acting antivirals are better tolerated in patients with hepatitis C virus infections vs. interferon-based therapy.
PCPs can “play a decisive role in eradicating” hepatitis C virus in the U.S., says lead author of new study.
A new report finds that hepatitis B and C can be eliminated as a public health problem.
A new study highlights the need for hepatitis C virus screening of pregnant women to identify HCV-infected children and direct them to proper care. A significant number of babies born to women who are infected with the hepatitis C virus (HCV) remain untested for perinatal infections, according to a new study.
The protease and polymerase inhibitor proved effective and well tolerated in patients with hepatitis C virus and cirrhosis, according to a new study.
A new study explores what lifestyle hepatitis C virus (HCV) patients consider when directing their course of treatement.
Direct-acting antiviral (DAA) agents appear to have a less robust effect in “difficult-to-treat” patients, according to new research.
A new study indicates that infection with the hepatitis C virus (HCV) significantly increases the risk of developing Parkinson’s Disease.
The use of sofosbuvir and velpatasvir successfully treated hepatitis C virus infection in 90% of advanced liver disease patients, a new study notes.